China NMPA Product Recall - Hemodynamic Modularized Multi-parameter Monitoring Platform
China NMPA product recall for Hemodynamic Modularized Multi-parameter Monitoring Platform by Edwards Lifesciences LLC published March 18, 2022. Recall level: Level 2 Recall. On March 18, 2022, Edwards Lifesciences LLC, a medical technology company, initiated a voluntary Cla
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Hemodynamic Modularized Multi-parameter Monitoring Platform by Edwards Lifesciences LLC published March 18, 2022. Recall level: Level 2 Recall. On March 18, 2022, Edwards Lifesciences LLC, a medical technology company, initiated a voluntary Cla
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Edwards Lifesciences LLCInspection Date
Unknown Date
Product Type
ID: 352bc264-21c6-40a3-a339-1fd75f6c7602
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox